, an arachidonic acid derivative produced during inflammatory conditions, is an endogenous agonist of both transient receptor potential vanilloid 1 (TRPV1) receptors and cannabinoid CB1 receptors. Sensitization of capsaicin-sensitive lung vagal afferent (CSLVA) fibers by chemical mediators is important in the pathogenesis of hyperreactive airway diseases. We investigated the effect of the intravenous infusion of AEA (2 mg ⅐ kg Ϫ1 ⅐ ml Ϫ1 , 0.5 ml/min for 2 min) on the sensitivity of CSLVA fibers to chemical and mechanical stimulation in anesthetized rats. In artificially ventilated rats, AEA infusion only mildly elevated the baseline activity of CSLVA fibers. However, CSLVA fiber responses to right atrial injection of capsaicin, AEA, or adenosine and to lung inflation (tracheal pressure ϭ 30 cmH2O) were all markedly potentiated during AEA infusion, which reverted 20 min after termination of the infusion. The potentiating effect on the sensitivity of CSLVA fibers to adenosine injection or lung inflation was completely blocked by pretreatment with capsazepine (a TRPV1 receptor antagonist) but was unaffected by pretreatment with AM281 (a CB1 receptor antagonist). In spontaneously breathing rats, right atrial injection of adenosine evoked an apneic response that is presumably mediated through CSLVA fibers. Similarly, the adenosine-evoked apneic response was potentiated during AEA infusion, and this potentiating effect was also completely prevented by pretreatment with capsazepine. These results suggest that AEA infusion at the dose tested produces a mild activation of TRPV1 receptors and this nonspecifically increases CSLVA fiber sensitivity to chemical and mechanical stimulation.
capsaicin-sensitive lung vagal afferent fibers; afferent sensitization CAPSAICIN-SENSITIVE LUNG VAGAL afferents (CSLVAs), mainly C fibers and some A-␦ fibers, are nociceptive-like free nerve endings that play an important role in the regulation of respiratory functions under both normal and pathophysiological conditions (6, 30, 33, 45) . These lung afferent fibers can be stimulated by a variety of chemical mediators (30, 34, 40, 45) or inhaled irritants (6, 26, 27, 30) , leading to elicitation of various airway reflexes including cough and bronchoconstriction (6, 30) . Thus the sensitization of CSLVA fibers by inflammatory mediators has been implicated in the pathogenesis of hyperreactive airway diseases such as chronic cough and asthma (31, 50) .
Studies of the afferent responses of CSLVA fibers to certain agonists have revealed that various types of pharmacological receptors may be located on the membrane of their nerve terminals (30, 45) . Activation of several types of these pharmacological receptors by chemical mediators may result in sensitization of the CSLVA fibers. For examples, previous investigations have shown that bradykinin (14) , histamine (29) , prostaglandin E 2 (19, 25) , adenosine (18) , and epinephrine (17) , possibly via activation of their specific receptors, increase the excitability of CSLVA fibers or vagal airway capsaicinsensitive afferent neurons. Among these pharmacological receptors, transient receptor potential vanilloid 1 (TRPV1) receptors, a type of ligand-gated nonselective cation channel, are polymodal receptors that are sensitive to various stimuli including intense heat, acidic solutions, capsaicin, certain endocannabinoids, and various metabolites of arachidonic acid (6, 45) . The TRPV1 receptors located on the airway sensory nerves have been suggested to play a vital role in the development of hyperreactive airway diseases (4, 15, 16, 21) . Previous studies have reported that intense and repetitive activation of the TRPV1 receptors by large doses of capsaicin (the pungent agent of hot chili peppers) produces a desensitization of the capsaicin-sensitive afferent fibers or sensory neurons (28, 43, 47, 51) . However, it is known that the endogenous ligands for TRPV1 receptors and the endovanilloids generally have a lower potency compared with capsaicin (42, 49) . Thus the effect of mild stimulation of TRPV1 receptors by their endogenous ligands on the excitability of CSLVA fibers is still unclear.
Anandamide (N-arachidonoylethanolamine; AEA), an arachidonic acid derivative, is released from macrophages, basophils, neurons, and epithelium (9, 11, 12) and is synthesized in the lungs (5) . Several investigators have suggested that AEA is produced during various types of inflammatory conditions (13, 35, 36) . AEA was originally recognized as an endogenous agonist of the cannabinoid CB1 receptor (10) and later was also demonstrated to be an endogenous ligand of the TRPV1 receptor (39, 41, 42, 49) . Indeed, administration of AEA stimulates CSLVA fibers (23, 32, 34) and evokes CSLVA fiber-mediated consequences such as respiratory reflexes (22, 34) and airway constriction (32, 48) in rats or guinea pigs. The effects of AEA can be prevented by antagonists of TRPV1 receptors, indicating that the effect is specific (22, 34, 48) . Like other endovanilloids, AEA stimulates CSLVA fibers (32, 34) and TRPV1 receptors (3, 39, 42) with a potency that is much lower than that of capsaicin. The effect of AEA on the excitability of CSLVA fibers is not known.
The present study was undertaken 1) to investigate the potentiating effect of AEA on the afferent responses of CSLVA fibers to chemical and mechanical stimulation with a single-fiber recording technique in anesthetized, artificially ventilated rats; 2) to determine the role of the TRPV1 and CB1 receptors in the AEA-induced sensitization of CSLVA fibers; and 3) to assess the role of the TRPV1 receptors in the AEA-induced augmentation of CSLVA fiber-mediated cardiorespiratory reflexes in anesthetized, spontaneously breathing rats. To accomplish these objectives, afferent and cardiorespiratory responses to chemical or mechanical stimuli were compared before and during intravenous infusion of AEA and its vehicle. Capsaicin (28) , AEA (34) , and adenosine (7, 20) were employed as chemical stimulants of CSLVA fibers, while lung inflation was used as the mechanical stimulus (19) . Since capsaicin and AEA are agonists for TRPV1 receptors, CSLVA fiber responses to adenosine and lung inflation before and after pretreatment with a TRPV1 receptor antagonist were investigated to determine the role of TRPV1 receptors in the sensitizing effect of the AEA infusion. Furthermore, CSLVA fiber responses to adenosine and lung inflation were studied to delineate whether the sensitization of CSLVA fibers by AEA infusion is specific to the activation by TRPV1 receptor agonists or nonspecific to other stimulants for these fibers. Additionally, capsazepine, a selective antagonist of TRPV1 receptors (28) , and AM281, a selective antagonist of CB1 receptors (8) , were employed to delineate the role of these two types of pharmacological receptors in the sensitizing effect of the AEA infusion.
MATERIALS AND METHODS
Animal preparation. The procedures described below were in accordance with the recommendations found in the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health and were approved by the Institutional Animal Care and Use Committee of Taipei Medical University. Male Sprague-Dawley rats were anesthetized with an intraperitoneal injection of chloralose (100 mg/kg; Sigma, St. Louis, MO) and urethane (500 mg/kg; Sigma) dissolved in a borax solution (2%; Sigma). A polyethylene catheter was inserted into the jugular vein and advanced until the tip was close to the right atrium for injection of pharmacological agents. The right femoral artery and vein were cannulated to allow measurement of arterial blood pressure and for infusion of AEA, respectively. During the course of the experiments, supplemental doses of chloralose (20 mg ⅐ kg Ϫ1 ⅐ h Ϫ1 ) and urethane (100 mg ⅐ kg Ϫ1 ⅐ h Ϫ1 ) were administered to maintain the abolition of the corneal reflex and the pain reflex induced by pinching the animal's tail. Body temperature was maintained at ϳ37°C throughout the experiment by means of a servocontrolled heating blanket.
The animal's neck was opened along the midline. A short tracheal cannula was inserted just below the larynx via a tracheostomy and connected to a pneumotachograph (Hans-Rudolph 8420, Kansas City, MO), through which the animals breathed spontaneously. Respiratory flow was measured with a pneumotachograph coupled to a differential pressure transducer (Validyne MP45-12, Northridge, CA). The flow signal was integrated to give tidal volume (VT). Tracheal pressure (P t) was monitored with a pressure transducer (Validyne MP45-28) via a side tap to the tracheal cannula. All physiological signals were recorded on a chart recorder (Gould TA11, Cleveland, OH) and a tape recorder (Neurocorder DR-890, New York, NY) for later analysis.
For measurement of breathing pattern responses, rats breathed spontaneously via the tracheal cannula. For measurement of neural activity arising from CSLVA fibers, rats received a midline thoracotomy and both vagus nerves were ligated just above the diaphragm to eliminate afferent signals arising from the lower visceral organs. The lungs were then ventilated by a rodent respirator (Harvard 683, South Natick, MA) at a constant volume of 8 ml/kg. The frequency of the respirator was set at 50 breaths/min and was kept constant in each experiment. The expiratory outlet of the respirator was placed under 3 cm of water to maintain a near-normal functional residual capacity.
Recording of CSLVA fiber activity. Neural activity arising from the CSLVA fibers was recorded with techniques described elsewhere (26, 34) . Briefly, a fine afferent filament of the right vagus nerve was split from the desheathed right nerve trunk lying on a platform and placed on a platinum-iridium unipolar recording electrode to record afferent nerve activity. To search for these afferent fibers, the lungs were hyperinflated in a stepwise manner to 3 or 4 ϫ VT; CSLVA fibers are activated by lung hyperinflation at this high volume level (30) . The thin filament was further split until the afferent activity arising from a single unit was electrically isolated. The recording of a single fiber was confirmed by matching spike templates. Once the presence of a suspected single unit was detected, capsaicin (1 g/kg; Sigma) was injected as a bolus into the right atrium. Only afferent fibers that showed stimulation within 2 s after the injection were studied. Before the end of each experiment, the general locations of all fibers were identified by their responses to the gentle pressing of the lungs with a saline-wetted cotton Q-tip.
Pharmacological agents. The stock solution of AEA (7.5 mg/ml; Sigma) was prepared in a vehicle of 50% ethanol and 50% emulphor (EL-620; Rhodia, Cranbury, NJ). The stock solution of capsaicin (250 g/ml; Sigma) was prepared in 1% Tween 80, 1% ethanol, and 98% saline. The stock solution of adenosine (75 mg/ml; Sigma) was prepared in saline. The stock solution of capsazepine (Sigma) was first dissolved in dimethyl sulfoxide (Sigma) at a concentration of 0.1 M and further diluted with saline containing 10% Tween 80 and 10% ethanol to a concentration of 3 mg/ml. The stock solution of AM281 (Tocris, Ballwin, MO) was first dissolved in dimethyl sulfoxide at a concentration of 1.2 mg/ml. The stock solution of AEA was stored at Ϫ80°C; the others were stored at Ϫ20°C. Solutions of these chemical agents at the desired concentrations for infusion or injection were prepared daily by dilution with isotonic saline to a concentration based on the animal's body weight.
Pharmacological treatments. AEA solution (2 mg ⅐ kg Ϫ1 ⅐ ml Ϫ1 ) was slowly infused into the vein at a constant rate of 0.5 ml/min for 2 min with a syringe pump (Kent Scientific, Torrington, CT). Capsaicin (0.5-1 g/kg), AEA (0.4 mg/kg), and adenosine (0.2-0.6 mg/kg) were separately injected into the vein as a bolus. Each of these drugs was then flushed into the right atrium by an injection of 0.3 ml of saline. Capsazepine (3 mg/kg), AM281 (0.3 mg/kg), and the vehicle of capsazepine were separately injected into the vein as a bolus. The infusion dose of AEA for sensitization of the CSLVA fibers had been determined during a preliminary study. The injection doses of capsaicin (40) , adenosine (19, 20, 24) , and AEA (34) to stimulate the CSLVA fibers as well as the doses and the activity time of capsazepine (28, 40) and AM281 (8) for the effective blockade of the TRPV1 and CB1 receptors, respectively, were determined from previous studies.
Experimental design and protocols. In this study, 98 rats (weight 350 -470 g) were divided into 13 groups to conduct 5 series of experiments. Each group in study series 1-3 contained eight rats, and only one CSLVA fiber was studied in each rat. Each group in study series 4 and 5 contained six rats. Figure 1 depicts the procession of the protocols, and Table 1 shows various experimental interventions in the study groups tested. In study series 1 (Fig. 1A) , the effect of intravenous infusion of AEA on CSLVA fiber responses to chemical stimulation was examined in artificially ventilated rats. The chemical stimulation was separately induced by right atrial injection of the three chemical stimulants of CSLVA fibers, capsaicin (group 1), AEA (group 2), and adenosine (group 3). For each fiber, infusions of AEA and its vehicle were performed in alternative order with an elapsed time of 60 min between the two infusions. For each infusion, right atrial bolus injection of the chemical stimulant was performed 20 min before, 1.5 min after the onset of, and 20 min after the termination of infusion. In study series 2 (Fig. 1A) , the effect of an intravenous infusion of AEA on CSLVA fiber responses to mechanical stimulation was examined in artificially ventilated rats (group 4). Mechanical stimulation was induced by constant-pressure lung inflation, which inflated the lung with a constant airflow (ϳ12 ml/s) until P t reached 30 cmH2O; the lungs were then maintained at that pressure for 10 s after the respirator was turned off. The protocol of this study series was the same as that of study series 1 except that chemical stimulation was replaced by lung inflation. In study series 3 (Fig. 1B) , the effects of intravenous infusion of AEA on CSLVA fiber responses to lung inflation and right atrial bolus injection of adenosine were compared before and after pretreatment with an antagonist of the TRPV1 receptors, with an antagonist of the CB1 receptors, and with its vehicle in artificially ventilated rats. Since capsaicin and AEA are agonists of TRPV1 receptors, only adenosine was employed to stimulate CSLVA fibers in this study series. As controls, either lung inflation (groups 5-7) or right atrial injection of adenosine (groups 8 -10) was performed 20 min before, 1.5 min after the onset of, and 20 min after the termination of AEA infusion. Subsequently, studies were repeated to investigate the effect of receptor antagonists. Pretreatments with capsazepine (groups 5 and 8) and its vehicle (groups ) and its vehicle were slowly infused into the vein at a constant rate of 0.5 ml/min for 2 min. An elapsed time of 60 min was allowed between 2 infusions. For each infusion, right atrial injections of capsaicin (0.75 g/kg), indicated by arrows, were performed 20 min before, 1.5 min after the onset of, and 20 min after the termination of infusion. AP, action potential; Pt, tracheal pressure; ABP, arterial blood pressure. Note that the fiber response to capsaicin was enhanced during AEA infusion but was unaffected during vehicle infusion. 6 and 9) were made 1.5 min before the onset of AEA infusion, and pretreatments with AM281 (groups 7 and 10) were made 10 min before the onset of AEA infusion. In study series 4 (Fig. 1A) , the effects of intravenous infusion of AEA on cardiorespiratory responses to right atrial injection of adenosine were studied in spontaneously breathing rats (group 11). The protocol of this study series was the same as that of study series 1. In study series 5 (Fig. 1B) , the effect of intravenous infusion of AEA on cardiorespiratory responses to right atrial injection of adenosine was compared before and after pretreatment with an antagonist of TRPV1 receptors or its vehicle in spontaneously breathing rats. Right atrial bolus injection of adenosine was performed 20 min before, 1.5 min after the onset of, and 20 min after the termination of AEA infusion. Subsequently, studies were repeated to investigate the effect of receptor antagonist. Pretreatments with capsazepine (group 12) and its vehicle (group 13) were made 1.5 min before the onset of AEA infusion.
Data analysis and statistics. For the electrophysiological studies, CSLVA fiber activity (FA) was continuously analyzed at 1-s intervals over an interval of at least 20 s before and 60 s after mechanical or chemical stimulation. Baseline FA was calculated as the average value over the 10-s period immediately preceding injection of chemical stimulants or lung inflation. The peak response was defined as the maximum 2-s average during the 20 s following the injection of the chemical stimulant or over 5 s after lung inflation. For the breathing pattern studies, expiratory durations (TE) were analyzed on a breathby-breath basis over an interval of at least 20 breaths before and 60 breaths after the chemical stimulation. Baseline TE was calculated as the average value over the 10-breath period immediately preceding injection of the chemical stimulant. To compare the apneic response evoked by different experimental conditions, the longest TE occurring during the first 20 s after injection of chemical stimulant was divided by the baseline TE to yield the apneic ratio. In all studies, heart rate (HR) and mean arterial blood pressure (MABP) were continuously analyzed at 1-s intervals. These physiological parameters were analyzed with a computer equipped with an analog-to-digital converter (Gould DASA 4600) and software (BioCybernatics, 1.0; Taipei, Taiwan). The results obtained from the computer analysis were routinely checked with those obtained by manual calculations for accuracy. Data were compared by two-way repeated-measures ANOVA test followed by Neuman-Keuls test when appropriate. A value of P Ͻ 0.05 was considered significant. All data are presented as means Ϯ SE.
RESULTS

Effects of AEA infusion on baseline CSLVA fiber activity in artificially ventilated rats.
A total of 80 CSLVA fibers were studied in this investigation, and all these afferent fibers were localized within the lung structure. Twelve of these CSLVA fibers had sparse activity, whereas the remaining 68 had no baseline activity (Fig. 2) . In these 12 CSLVA fibers, AEA infusion increased the baseline FA to 435 Ϯ 108% of the original baseline activity (0.17 Ϯ 0.02 impulses/s). As a group, Data (means Ϯ SE) are values averaged over 10-s periods immediately before, 1.5 min after onset of, and 20 min after termination of infusion; n ϭ animal or fiber no. AEA (2 mg ⅐ kg Ϫ1 ⅐ ml Ϫ1 ) and its vehicle were slowly infused into the vein at a constant rate of 0.5 ml/min for 2 min. Only 1 capsaicin-sensitive lung vagal afferent (CSLVA) fiber was studied in each rat. *P Ͻ 0.05 vs. corresponding baseline value.
infusion of AEA caused a small but significant increase in baseline FA, whereas infusion of AEA vehicle had no such effect (Table 2 ). This small increase in baseline FA was not detectable 20 min after termination of the AEA infusion (Table  2) . Additionally, infusion of AEA and its vehicle did not significantly alter baseline HR, whereas both infusions slightly elevated MABP ( Table 2) .
Sensitization of CSLVA fibers by AEA in artificially ventilated rats: chemical stimulation. During the control condition, right atrial bolus injection of capsaicin (Figs. 2 and 3A) and AEA (Fig. 3B) rapidly evoked a mild, short burst of discharge by the CSLVA fibers tested. As a group, the difference between the mean peak response and the baseline FA (⌬FA) was 1.81 Ϯ 0.67 impulses/s (n ϭ 8) in response to the capsaicin injection (Fig. 4A ) and 1.57 Ϯ 0.32 impulses/s (n ϭ 8) in response to the AEA injection (Fig. 4B) . During AEA infusion, the stimulatory effect of the same doses of capsaicin (Figs. 2B and 3A) and AEA (Fig. 3B ) on these CSLVA fibers was significantly increased with regard to both duration and peak activity of firing. The durations of firing evoked by capsaicin before and during AEA infusion were 2.4 Ϯ 0.6 and 5.0 Ϯ 0.7 s (n ϭ 8), respectively. The durations of firing evoked by AEA before and during AEA infusion were 4.1 Ϯ 0.6 and 8.3 Ϯ 1.1 s (n ϭ 8), respectively. The fiber response evoked by capsaicin (Fig. 4A) and AEA (Fig. 4B ) injection during AEA infusion were increased by 5.2-fold and 6.0-fold, respectively, relative to the responses before infusion. The responses to capsaicin (Figs. 2B, 3A , and 4A) and AEA (Figs. 3B and 4B) had returned to control level when these CSLVA fibers were tested again 20 min after termination of the AEA infusion. In contrast, an infusion of AEA vehicle did not significantly alter the CSLVA fiber responses to capsaicin (Figs. 2A, 3A , and 4A) or AEA (Figs. 3B and 4B) .
The sensitizing effect of AEA infusion on the CSLVA fiber responses to stimulation by adenosine was similar to that of stimulation by capsaicin or AEA. During the control condition, right atrial bolus injection of adenosine stimulated the CSLVA fibers tested and ⌬FA reached 0.55 Ϯ 0.20 impulses/s (n ϭ 8; baseline activity ϭ 0.03 Ϯ 0.02 impulses/s) (Figs. 3C and 4C) .
Likewise, the CSLVA fiber response to the same dose of adenosine injection was significantly increased during AEA infusion (6.8 fold of response before infusion) but was unaltered during vehicle infusion (Figs. 3C and 4C) . The potentiating response to chemical stimulation by adenosine was also Data are means Ϯ SE. Responses to capsaicin, AEA, and adenosine (I) were separately observed in 3 groups of artificially ventilated rats, while responses to adenosine (II) were observed in 1 group of spontaneously breathing rats. MABP, mean arterial blood pressure; HR, heart rate; Ϫ⌬MABP and Ϫ⌬HR, peak response Ϫ baseline. Baselines are values averaged over 10-s periods immediately before injection of chemical stimulant. Peak responses are lowest values averaged over 2-s periods during first 20 s after injections. See Table 1 for further explanation. *P Ͻ 0.05 vs. value before infusion in same group; †P Ͻ 0.05 vs. value at corresponding time point in vehicle group. Bolus injections of capsaicin, AEA, or adenosine induced decreases in HR and MABP, both of which were presumably elicited by stimulation of the CSLVA fibers by these chemical stimulants (24, 28, 33) . During AEA infusion, the cardiovascular depressor response to the same dose of the chemical stimulants was also significantly augmented ( Fig. 2 and Table 3 ). This potentiating effect was not seen at 20 min after termination of the AEA infusion ( Fig. 2 and Table 3) .
Sensitization of CSLVA fibers by AEA in artificially ventilated rats: mechanical stimulation. The potentiating effect of AEA infusion was not restricted to the response to chemical stimulation. During the control condition, mechanical stimulation by inflation of the lungs to a P t of 30 cmH 2 O only weakly stimulated the CSLVA fibers tested (Fig. 5A) ; ⌬FA reached 0.73 Ϯ 0.33 impulses/s (n ϭ 8; baseline activity ϭ 0.02 Ϯ 0.02 impulses/s) (Figs. 3D and 4D) . Similarly, the fiber response to lung inflation increased during AEA infusion (6.1-fold of response before infusion) but was unaltered during vehicle infusion (Figs. 3D, 4D, and 5A ). This potentiating effect on the response to lung inflation was also reversible within 20 min after termination of the AEA infusion (Figs. 3D, 4D, and 5A) .
Role of TRPV1 receptors in sensitization of CSLVA fibers by AEA in artificially ventilated rats. Pretreatment with capsazepine (a TRPV1 receptor antagonist) did not affect the CSLVA fiber response to adenosine (Fig. 6 ) or lung inflation (Fig. 5 ) evoked before AEA infusion; ⌬FA evoked by either stimulation before and after capsazepine did not differ significantly (Fig. 7A) . However, pretreatment with capsazepine prevented the increase in baseline FA induced by AEA infusion; baseline FA before and during AEA infusion was 0.03 Ϯ 0.01 and 0.02 Ϯ 0.02 impulses/s (P Ͼ 0.05; n ϭ 16), respectively. Additionally, pretreatment with capsazepine completely blocked the potentiating effect of AEA infusion on the CSLVA fiber response to adenosine (Fig. 6 ) or lung inflation (Fig. 5) . After capsazepine pretreatment, the fiber response evoked by adenosine (Fig. 7A, left) or lung inflation (Fig. 7A, right) during AEA infusion was no longer greater than the response before infusion. Pretreatment with the vehicle of capsazepine, however, did not influence the potentiating effect of AEA infusion on the CSLVA fiber response to either stimulation (Fig. 7B) . Additionally, pretreatment with capsazepine completely blocked the augmenting effect of AEA infusion on adenosine-evoked cardiovascular depressor responses (Fig. 6 and Table 4 ), whereas pretreatment with its vehicle failed to do this (Table 4) . In contrast to the effects of capsazepine, pretreatment with AM281 (a CB1 receptor antagonist) failed to prevent the increase in baseline FA induced by AEA infusion; baseline FA before and during AEA infusion was 0.04 Ϯ 0.03 and 0.11 Ϯ 0.05 impulses/s (P Ͻ 0.05; n ϭ 16), respectively. Additionally, pretreatment with AM281 had no significant influence on the ) was slowly infused into the vein at a constant rate of 0.5 ml/min for 2 min. An elapsed time of 60 min was allowed between 2 infusions. For each infusion, constant-pressure lung inflation (Pt ϭ 30 cmH2O) was performed 20 min before, 1.5 min after onset of, and 20 min after termination of infusion. Note that pretreatment with capsazepine completely blocked the potentiating effect of AEA infusion on the fiber response to lung inflation. Fig. 6 . Effect of pretreatment with capsazepine on responses of a CSLVA fiber to right atrial bolus injection of adenosine before, during, and 20 min after infusion of AEA in an anesthetized, artificially ventilated rat. A and B: before and after pretreatment with CPZ (3 mg/kg), respectively. AEA (2 mg ⅐ kg Ϫ1 ⅐ ml Ϫ1 ) was slowly infused into the vein at a constant rate of 0.5 ml/min for 2 min. An elapsed time of 60 min was allowed between 2 infusions. For each infusion, right atrial injections of adenosine (0.4 mg/kg), indicated by arrows, were performed 20 min before, 1.5 min after the onset of, and 20 min after the termination of infusion. Note that pretreatment with CPZ completely blocked the potentiating effect of AEA infusion on the fiber response to adenosine injection.
potentiating effect of AEA infusion on the CSLVA fiber response to adenosine or lung inflation (Fig. 7C) .
Role of TRPV1 receptors in AEA-induced augmentation of CSLVA fiber-mediated cardiorespiratory responses to adenosine in spontaneously breathing rats. During the control condition, right atrial bolus injection of adenosine evoked a respiratory inhibition, which was manifested by an apnea followed by several breaths involving respiratory slowing (Fig. 8) . This apneic response was primarily due to a mild prolongation of TE and was accompanied by decreases in both HR and MABP (Fig. 8) . These cardiorespiratory responses have been shown to be the reflex consequences resulting from stimulation of CSLVA fibers by adenosine (20, 24) . During AEA infusion, both the adenosine-evoked apneic and cardiovascular depressor responses were magnified ( Fig. 8 and Table 3 ). As a group, the apneic ratio evoked by adenosine was significantly increased during AEA infusion but was unaltered during infusion with AEA vehicle (Fig. 9) . These potentiating cardiorespiratory responses to adenosine injection were not observed at 20 min after termination of the AEA infusion (Figs. 8 and 9 , Table 3 ). Additionally, pretreatment with capsazepine completely blocked the potentiating effect of AEA infusion on the cardiorespiratory responses to adenosine ( Fig. 10 and Table 4 ). After capsazepine pretreatment, the apneic ratio evoked by adenosine during AEA infusion was no longer greater than that before AEA infusion (Fig. 10) . However, pretreatment with the vehicle of capsazepine did not influence the potentiating effect of AEA infusion on the apneic ratio evoked by adenosine (Fig. 10) . Fig. 7 . Effects of pretreatment with CPZ (A) or its vehicle (B) and with AM281 (C) on the sensitizing effects of AEA infusion on the CSLVA fiber response to right atrial bolus injection of adenosine and to lung inflation. In the responses to adenosine injections (left), ⌬FA was measured as differences between peak FA (averaged over 2-s intervals) and baseline FA in each fiber. In the response to lung inflation (right), ⌬FA was measured as differences between peak FA during inflation (averaged over a 5-s interval) and baseline FA. *P Ͻ 0.05 vs. value before infusion in same group; a P Ͻ 0.05 vs. value at corresponding time period in group before pretreatment. Data in each group are means Ϯ SE of 8 fibers recorded from 8 rats. See Figs. 5 and 6 for further explanation. Fig. 8 . Ventilatory responses to right atrial bolus injection of adenosine before, during, and 20 min after infusion of AEA (B) or its vehicle (A) in an anesthetized, spontaneously breathing rat. AEA (2 mg ⅐ kg Ϫ1 ⅐ ml Ϫ1 ) and its vehicle were slowly infused into the vein at a constant rate of 0.5 ml/min for 2 min. An elapsed time of 60 min was allowed between any 2 infusions. For each infusion, right atrial injections of adenosine (0.6 mg/kg), indicated by arrows, were performed 20 min before, 1.5 min after the onset of, and 20 min after the termination of infusion. V , respiratory flow; VT, tidal volume. Note that the apneic response evoked by adenosine injection was enhanced during AEA infusion but was unaffected during vehicle infusion.
DISCUSSION
Results of this study demonstrate that intravenous infusion of AEA at a dose of 2 mg⅐kg Ϫ1 ⅐ml Ϫ1 and a rate of 0.5 ml/min for 2 min only caused a slight elevation in the baseline activity of CSLVA fibers, suggesting a mild stimulation of these afferents. This is in comparison to the intense stimulation of CSLVA fibers evoked by right atrial bolus injection of AEA at a relatively large dose range of 0.4 -0.6 mg/kg reported in a recent study (34) . Under this infusion condition, CSLVA fiber responses to chemical stimulation by right atrial bolus injection of capsaicin, AEA, or adenosine and to mechanical stimulation by lung inflation were all markedly potentiated. Additionally, the potentiating effect of AEA infusion on CSLVA fiber response to adenosine injection or lung inflation was totally prevented after pretreatment with a selective TRPV1 receptor antagonist but was unaffected by pretreatment with a selective CB1 receptor antagonist. We further demonstrate that right atrial bolus injection of adenosine triggered an apneic response that is presumably mediated through CSLVA fibers (20, 24) . Consistent with our findings from the electrophysiological study, AEA infusion also augmented the apneic response to the adenosine injection and this potentiating effect was also prevented by pretreatment with the selective TRPV1 receptor antagonist. Together, these results suggest that AEA infusion induces a nonspecific potentiating effect on the sensitivity of CSLVA fibers to chemical and mechanical stimulation in rat lungs, and this effect is likely mediated through activation of the TRPV1 receptors.
The possibility that a mild activation of TRPV1 receptors by their agonist may sensitize CSLVA fibers has not been reported previously. Both the functioning of TRPV1 receptors and the sensitization of CSLVA fibers currently are important research topics in the pathogenesis of hyperreactive airway diseases (15, 30, 45) . Several studies have reported that activation of pharmacological receptors other than TRPV1 receptors by chemical mediators may sensitize TRPV1 receptor function, leading to an increase in the sensitivity of CSLVA fibers or vagal airway capsaicin-sensitive afferent neurons to capsaicin stimulation (14, 17-19, 25, 29) . On the other hand, several investigations have shown that repetitive or prolonged activation of the TRPV1 receptors by large doses of capsaicin can result in desensitization of TRPV1 receptor function in capsaicin-sensitive afferent fibers or neurons (28, 43, 47, 51) . As such, our finding that AEA, via activation of the TRPV1 receptors, sensitizes CSLVA fibers in response to various types of stimuli reveals a novel role for these receptors in the pathogenesis of hyperreactive airway diseases. Our observations gain support from the finding that, in transfected mammalian cells expressing TRPV1 receptors, protons may act as an agonist of these receptors and potentiate TRPV1 receptor responses to capsaicin or heat (46) . Our findings are also consistent with another report (13) showing that AEA sensitizes capsaicin-sensitive bladder afferents and induces bladder hyperreflexia during cystitis in rats. Similar to our findings, this sensitizing effect of AEA is prevented by a selective TRPV1 receptor antagonist, suggesting that the effects are mediated through activation of the TRPV1 receptors (13) .
The mechanism by which the intravenous infusion of such a low dose of AEA dramatically enhances the sensitivity of CSLVA fibers to different chemical stimulants and lung inflation is not clear. However, it is known that the TRPV1 receptor is a nonselective cationic channel (47) . Furthermore, the stimulatory action of adenosine on CSLVA fibers is known to be mediated through activation of specific metabotropic receptors, whereas mechanical stimulation of lung vagal afferents possibly involves as yet unidentified mechanogating cationic channels in the membrane of nerve terminals (45) . In view of the fact that CSLVA fiber responses to injections of capsaicin, AEA, or adenosine and to lung inflation were all potentiated, it appears that activation of TRPV1 receptors by AEA infusion produces a nonspecific increase in the electrical excitability of CSLVA fibers. Alternatively, activation of TRPV1 receptors by AEA infusion may possibly promote a common cellular mechanism that sensitizes the function of these ionotropic and metabotropic receptors. To this end, certain lipoxygenase metabolites that originate from AEA metabolism by enzymes may act as potential TRPV1 receptor agonists (39, 42) . The possible contribution of indirect activation of TRPV1 receptors by these metabolites to the sensitizing effect of AEA infusion needs to be considered. Fig. 9 . Effects of infusion of AEA (A) or its vehicle (B) on the apneic response to right atrial bolus injection of adenosine in 1 group of anesthetized, spontaneously breathing rats. Apneic ratio was defined as longest expiratory duration (TE) occurring during first 20 s after adenosine injection divided by baseline TE. *P Ͻ 0.05 vs. value before infusion; a P Ͻ 0.05 vs. value at corresponding time period in group with AEA infusion. Data in each group are means Ϯ SE of 6 rats. See Fig. 8 for further explanation. Fig. 10 . Effects of pretreatment with CPZ (A) or its vehicle (B) on the potentiating effects of AEA infusion on the apneic response evoked by right atrial bolus injection of adenosine in 2 groups of anesthetized, spontaneously breathing rats. Apneic ratio was defined as longest TE occurring during first 20 s after adenosine injection divided by baseline TE. *P Ͻ 0.05 vs. value before AEA infusion in the same group; a P Ͻ 0.05 vs. value at corresponding time period in group before pretreatment. Data in each group are means Ϯ SE of 6 rats.
AEA has been identified not only as an endogenous ligand of the TRPV1 receptor but also as an endogenous agonist of the CB1 receptor (10, 39, 42) . Several studies have also shown that AEA induces a CB1 receptor-mediated negative regulation of TRPV1 receptor function in capsaicin-sensitive primary sensory neurons (1, 38) . In rat nociceptive primary sensory neurons (2) or airways (5), the presence of CB1 receptors at nerve terminals has been demonstrated. AEA produces a dual TRPV1-CB1 receptor agonist effect on release of neuropeptides from rat airway sensory nerves depending on its concentration (37) . Additionally, AEA induces CB1 receptor-mediated inhibition of the airway reflex responses evoked by intravenous injection of capsaicin at a dose of 100 g/kg in rodents (5). However, the differing doses of capsaicin used in the present study and that study (5) predispose us to uncover this inhibitory effect of AEA. The stimulation of rat CSLVA fibers by AEA, however, is mediated solely through its action on TRPV1 receptors (34) . In the present study, the potentiating effect of AEA infusion on the CSLVA fiber response to adenosine or lung inflation was unaffected by pretreatment with a CB1 receptor antagonist (8) . Thus it appears that CB1 receptors play no functional role in the AEA-induced increase in excitability of CSLVA fibers observed in this study.
Because of its low potency, the role of AEA as an endogenous ligand in the activation of TRPV1 receptors was originally controversial (44) . In this study, we found that AEA infusion potentiates the CSLVA fiber response to right atrial bolus injection of AEA. This finding implies that a preexposure to AEA is capable of increasing the potency of any subsequent AEA activation of TRPV1 receptors located at the terminals of CSLVA fibers. Our finding thus provides additional evidence that favors the role of AEA as an endogenous TRPV1 receptor ligand.
During the control condition, bolus injection of any of the CSLVA fiber stimulants tested caused a transient but prominent bradycardia and hypotension that coincided with the afferent responses by the artificially ventilated rats or with the ventilatory responses by the spontaneously breathing rats. These cardiovascular depressor responses are believed to be reflex consequences resulting from stimulation of the CSLVA fibers (24, 28, 30, 34 ). This notion gains support from the observations that, in concert with afferent and ventilatory responses, these cardiovascular depressor responses were also augmented by AEA infusion and the potentiating effect of AEA infusion could be prevented after pretreatment with the selective TRPV1 receptor antagonist.
In this study, we employed a strategy to infuse AEA at a low dose over a certain period of time to stimulate the CSLVA fibers. After infusion into the vein, the concentration of AEA is presumably diluted by the blood and further diluted when AEA is in close proximity to the CSLVA fibers. Endogenous biosynthesis of AEA has been shown to occur in various tissues including the lungs (5, 9, 13, 36). However, the production and potency of AEA vary across different tissues and experimental conditions (39, 42) , and the exact range of the AEA concentration in extracellular fluid is still unclear. Accordingly, we still do not know whether the concentrations of AEA that were tested reach a level in the tissues similar to that of endogenous AEA.
In this study, extrapulmonary adenosine-sensitive afferents might contribute to the reflex responses to adenosine. The similarity of the cardiovascular depressor responses to adenosine in artificially ventilated rats and spontaneously breathing rats supports the pulmonary origin of these reflex responses, because the subdiaphragmatic vagal afferents were absent in the former experimental condition. However, the contribution of nonvagal afferents cannot be excluded.
In conclusion, the results from the present study have clearly demonstrated a sensitizing effect of AEA on CSLVA fibers in anesthetized rats. This sensitizing effect results in a nonspecific increase in the electrical excitability of CSLVA fibers and augmented ventilatory responses to chemical stimulant of CSLVA fibers. This sensitizing effect appears to be mediated through an activation of the TRPV1 receptor, which is presumably located at terminals of CSLVA fibers. Data are means Ϯ SE. Responses to adenosine (I) were observed in 2 groups of artificially ventilated rats (each n ϭ 8), whereas responses to adenosine (II) were observed in 2 groups of spontaneously breathing rats (each n ϭ 6). Ϫ⌬MABP and Ϫ⌬HR, differences between mean peak responses to chemical stimulants and baseline. Baselines are values averaged over 10-s periods immediately before injections of chemical stimulant. Mean peak responses are lowest values averaged over 2-s periods during first 20 s after injections. See Table 1 for further explanation. *P Ͻ 0.05 vs. value before infusion in same group. †P Ͻ 0.05 vs. value at corresponding time point in group before capsazepine.
